Antifungal drug resistance in Candida species

Abstract

There has been a significant increase in the number of reports of mucosal and systemic infections caused by Candida spp. in recent years. Despite the increase in the infection rates by Candida spp., therapeutic options for their treatment are relatively limited. In the recent years, there has been a marked increase in the incidence of treatment failures in candidosis patients receiving long term therapy, which poses a serious problem in the treatment of infections caused by Candida spp.